So in the trading update, we learn that up to 3 weeks earlier, NCCN have upgraded Sir Spheres from Category 3 level of evidence to Category 2A.
Was this material information that should have been released by way of ASX release?. Even if it was not determined as being material, surely this should have been released to the ASX as a positive development for SRX. This is at best highly complacent and contemptuous behaviour by GW and co not to promote this development as soon as advice was received.
And as for CMS recently approving a 3% increase in payment rate of Sir Spheres to US$16501, I ask the same questions. Furthermore, when was RECENTLY ??!!
This CEO and board are clearly singing to their own hymn sheet and not working in the best interest of us shareholders.![]()
Add to My Watchlist
What is My Watchlist?